Invesco Oppenheimer Global Opp R5 (GOFFX)

63.67 +0.82  +1.30% Dec 12 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 63.67
Turnover Ratio 21.00%
1 Year Fund Level Flows -1.093B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 5.59% 2.48% 1
3M 9.55% 5.44% 1
6M 5.90% 7.95% 75
YTD 5.14% 22.99% --
1Y -- 17.57% --
3Y -- 10.13% --
5Y -- 7.98% --
10Y -- 8.84% --
15Y -- 7.22% --
20Y -- 5.90% --
As of Dec. 12, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 1.81% 1.81% 0.00%
Stock 98.19% 98.19% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2019

Region Exposure

Americas 48.06%
North America 48.06%
Latin America 0.00%
Greater Europe 40.35%
United Kingdom 10.58%
Europe Developed 29.78%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 11.58%
Japan 10.85%
Australasia 0.46%
Asia Developed 0.28%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets --
As of Sept. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 1.21%
Communication Services 0.65%
Consumer Cyclical 13.02%
Consumer Defensive 2.21%
Energy 0.00%
Financial Services 1.55%
Healthcare 27.22%
Industrials 11.32%
Real Estate 1.03%
Technology 41.80%
Utilities 0.00%
As of Sept. 30, 2019

Stock Market Capitalization

Giant 2.75%
Large 21.98%
Medium 40.50%
Small 24.84%
Micro 9.93%
As of Sept. 30, 2019

Stock Style Exposure

Large Cap Value 2.27%
Large Cap Blend 4.99%
Large Cap Growth 18.00%
Mid Cap Value 2.80%
Mid Cap Blend 8.25%
Mid Cap Growth 30.14%
Small Cap Value 2.05%
Small Cap Blend 3.32%
Small Cap Growth 28.20%
As of Sept. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
AMD Advanced Micro Devices Inc 7.30% 41.15 -3.38%
NKTR Nektar Therapeutics Inc 4.86% 21.28 -2.34%
EXAS Exact Sciences Corp 3.16% 87.19 +2.07%
QCOM Qualcomm Inc 2.13% 87.79 -1.41%
4587 PeptiDream Inc 2.00% -- --
ERF Eurofins Scientific SE 1.95% -- --
NVRO Nevro Corp 1.80% 109.06 +1.40%
GMAB Genmab A/S 1.71% -- --
FSLR First Solar Inc 1.62% 55.75 +1.29%
AFX Carl Zeiss Meditec AG 1.59% -- --
As of Sept. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks capital appreciation. The fund invests mainly in equity securities of issuers in the U.S. and foreign countries. It currently emphasizes investments in equities, but it may also invest in debt securities and may invest up to 25% of its assets in "below-investment-grade" securities, commonly known as "junk bonds." The fund typically invests in a number of different countries and can invest in any country, including countries with developing or emerging markets. It invests a substantial portion of its assets in small- and mid-sized companies.
General
Security Type Mutual Fund
Oldest Share Symbol OPGIX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name World Small/Mid Stock
Prospectus Objective World Stock
Fund Owner Firm Name Invesco
Benchmark Index
MSCI ACWI NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Frank Jennings 24.18 yrs

Share Classes

Symbol Share Class
OGICX C
OGIIX Inst
OGINX Retirement
OGIYX Inst
OPGIX A

Net Fund Flows

1M -125.31M
3M -422.52M
6M -831.96M
YTD -878.66M
1Y -1.093B
3Y 2.031B
5Y 1.673B
10Y 1.020B
As of Nov. 30, 2019

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) --
Daily Value at Risk (VaR) 1% (All) 3.38%
Monthly Value at Risk (VaR) 1% (All) 9.73%

Fundamentals

Dividend Yield TTM (12-12-19) 0.00%
30-Day SEC Yield --
7-Day SEC Yield (12-12-19) 0.00%
Weighted Average PE Ratio 28.32
Weighted Average Price to Sales Ratio 2.434
Weighted Average Price to Book Ratio 3.378
Weighted Median ROE 4.45%
Weighted Median ROA 2.02%
Forecasted Dividend Yield 0.93%
Forecasted PE Ratio 26.59
Forecasted Price to Sales Ratio 1.682
Forecasted Price to Book Ratio 1.812
Number of Holdings 146
As of Sept. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 13.75%
Forecasted Book Value Growth 7.90%
Forecasted Cash Flow Growth 0.77%
Forecasted Earnings Growth 64.95%
Forecasted Revenue Growth -1.79%
As of Sept. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 1.00M USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.67%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/24/2019
Termination Date
Last Annual Report Date
Last Prospectus Date 5/25/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.